This includes several molecularly-defined renal tumor entities, such as SMARCB1-deficient renal medullary carcinoma, TFEB-altered RCC, ALK-rearranged RCC, and ELOC-mutated RCC [5]. This evidence concerns the gene ELOC and renal cell carcinoma.